More articles from Discussions With Leaders

You have access
Translational Cancer Research Priorities and the Role of Molecular Imaging
Chi Van Dang, Elizabeth Jaffee and David Mankoff

Journal of Nuclear Medicine May 1, 2022, 63 (5) 637-639; DOI: https://doi.org/10.2967/jnumed.122.264086
You have access
Leadership in Patient Advocacy
Josh Mailman and Thomas A. Hope

Journal of Nuclear Medicine April 1, 2022, 63 (4) 497-499; DOI: https://doi.org/10.2967/jnumed.122.263989
You have access
Health Care and Nuclear Medicine in France
Dominique Le Guludec, Johannes Czernin and Jérémie Calais

Journal of Nuclear Medicine March 1, 2022, 63 (3) 327-330; DOI: https://doi.org/10.2967/jnumed.122.263863
You have access
A European Oncology Leader Looks at PSMA
Silke Gillessen, Johannes Czernin and Ken Herrmann

Journal of Nuclear Medicine February 1, 2022, 63 (2) 169-171; DOI: https://doi.org/10.2967/jnumed.121.263729
You have access
Advancing Nuclear Medicine in Australia over 3 Decades
Rodney Hicks, Johannes Czernin and Ken Herrmann

Journal of Nuclear Medicine January 1, 2022, 63 (1) 1-4; DOI: https://doi.org/10.2967/jnumed.121.263338
You have access
Molecular Imaging Leadership in Academia and Industry
Mark Mintun and David Mankoff

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1657-1659; DOI: https://doi.org/10.2967/jnumed.121.263451
You have access
Perspectives on Theranostics and Nuclear Medicine
Andrew M. Scott and Johannes Czernin

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1492-1494; DOI: https://doi.org/10.2967/jnumed.121.263243
You have access
Leadership Focus on Advancing Cancer Research and Treatment
Johannes Czernin, Caius Radu and Antoni Ribas

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1178-1180; DOI: https://doi.org/10.2967/jnumed.121.262937
You have access
Perspectives on Cutting-Edge Clinical Trials
Michael S. Hofman, Jérémie Calais and Johannes Czernin

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1027-1030; DOI: https://doi.org/10.2967/jnumed.121.262681
You have access
Perspectives on Radiopharmaceutical Agents from the FDA
Lou Marzella, Johannes Czernin and Thomas Hope

Journal of Nuclear Medicine July 1, 2021, 62 (7) 881-883; DOI: https://doi.org/10.2967/jnumed.121.262450

Main menu

User menu

Search

More articles from Discussions With Leaders

Pages